SZSE:002907 (China)
Â
Class A
Â¥
13.95
(+7.39%)
Sep 30
Business Description
Chongqing Pharscin Pharmaceutical Co Ltd
ISIN : CNE100003308
Share Class Description:
SZSE:002907: Class ACompare
Compare
Traded in other countries / regions
002907.China IPO Date
2017-10-20Description
Chongqing Pharscin Pharmaceutical Co Ltd is a China-based pharmaceutical research and development company. It produces and sells medicines in form of tablets, powders, granules, hard capsules, soft capsules, powder injection, freeze-dried powder injection, small volume injection, raw material synthesis and botanical extracts. It operates internationally.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 1977.68 | |||||
| Equity-to-Asset | 0.88 | |||||
| Interest Coverage | 5.4 | |||||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | 15.58 | |||||
| Beneish M-Score | -2.45 | |||||
| WACC vs ROIC | ||||||
Growth Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -9 | |||||
| 3-Year EBITDA Growth Rate | -15.7 | |||||
| 3-Year EPS without NRI Growth Rate | -39.2 | |||||
| 3-Year FCF Growth Rate | 22 | |||||
| 3-Year Book Growth Rate | 9.6 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 93.22 | |||||
| 9-Day RSI | 82.86 | |||||
| 14-Day RSI | 73.03 | |||||
| 6-1 Month Momentum % | -13.05 | |||||
| 12-1 Month Momentum % | -30.34 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 5.05 | |||||
| Quick Ratio | 4.34 | |||||
| Cash Ratio | 1.94 | |||||
| Days Inventory | 162.39 | |||||
| Days Sales Outstanding | 91.44 | |||||
| Days Payable | 62.7 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 0.61 | |||||
| Dividend Payout Ratio | 0.54 | |||||
| 3-Year Dividend Growth Rate | 16.7 | |||||
| Forward Dividend Yield % | 0.61 | |||||
| 5-Year Yield-on-Cost % | 0.66 | |||||
| 3-Year Average Share Buyback Ratio | -1.3 | |||||
| Shareholder Yield % | 2.5 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 55.56 | |||||
| Operating Margin % | 7.07 | |||||
| Net Margin % | 5.15 | |||||
| FCF Margin % | 14.25 | |||||
| ROE % | 2.36 | |||||
| ROA % | 2.05 | |||||
| ROIC % | 3.08 | |||||
| 3-Year ROIIC % | -35.57 | |||||
| ROC (Joel Greenblatt) % | 6.48 | |||||
| ROCE % | 3.16 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 150 | |||||
| PE Ratio without NRI | 150 | |||||
| Shiller PE Ratio | 41.03 | |||||
| PS Ratio | 7.77 | |||||
| PB Ratio | 3.54 | |||||
| Price-to-Tangible-Book | 3.92 | |||||
| Price-to-Free-Cash-Flow | 54.49 | |||||
| Price-to-Operating-Cash-Flow | 44.57 | |||||
| EV-to-EBIT | 95.22 | |||||
| EV-to-EBITDA | 95.22 | |||||
| EV-to-Revenue | 6.75 | |||||
| EV-to-FCF | 47.37 | |||||
| Price-to-Projected-FCF | 3.5 | |||||
| Price-to-Graham-Number | 5.11 | |||||
| Price-to-Net-Current-Asset-Value | 8.02 | |||||
| Price-to-Net-Cash | 42.27 | |||||
| Earnings Yield (Greenblatt) % | 1.05 | |||||
| FCF Yield % | 1.83 | |||||
| Forward Rate of Return (Yacktman) % | -23.46 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Chongqing Pharscin Pharmaceutical Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 748.939 | ||
| EPS (TTM) (Â¥) | 0.093 | ||
| Beta | 0.37 | ||
| Volatility % | 32.46 | ||
| 14-Day RSI | 73.03 | ||
| 14-Day ATR (Â¥) | 0.438977 | ||
| 20-Day SMA (Â¥) | 12.0535 | ||
| 12-1 Month Momentum % | -30.34 | ||
| 52-Week Range (Â¥) | 9.82 - 20.5 | ||
| Shares Outstanding (Mil) | 417.6 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Chongqing Pharscin Pharmaceutical Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Chongqing Pharscin Pharmaceutical Co Ltd Stock Events
| Event | Date | Price(Â¥) | ||
|---|---|---|---|---|
| No Event Data | ||||
Chongqing Pharscin Pharmaceutical Co Ltd Frequently Asked Questions
What is Chongqing Pharscin Pharmaceutical Co Ltd(SZSE:002907)'s stock price today?
The current price of SZSE:002907 is ¥13.95. The 52 week high of SZSE:002907 is ¥20.50 and 52 week low is ¥9.82.
When is next earnings date of Chongqing Pharscin Pharmaceutical Co Ltd(SZSE:002907)?
The next earnings date of Chongqing Pharscin Pharmaceutical Co Ltd(SZSE:002907) is .
Does Chongqing Pharscin Pharmaceutical Co Ltd(SZSE:002907) pay dividends? If so, how much?
The Dividend Yield %  of Chongqing Pharscin Pharmaceutical Co Ltd(SZSE:002907) is 0.61% (As of Today), Highest Dividend Payout Ratio of Chongqing Pharscin Pharmaceutical Co Ltd(SZSE:002907) was 1.4. The lowest was 0.1. And the median was 0.22. The  Forward Dividend Yield % of Chongqing Pharscin Pharmaceutical Co Ltd(SZSE:002907) is 0.61%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers